Trupanion Q2 revenue up 12%, beats estimates

Overview

• Trupanion Q2 revenue rises 12% yr/yr, beating analyst expectations, per LSEG data

• Net income for Q2 reaches $9.4 mln, reversing a loss from last year

Result Drivers

• SUBSCRIPTION GROWTH - Subscription business revenue rose 16%, driven by a 4% increase in enrolled pets

• INVESTMENT GAIN - Net income boosted by $7.8 mln gain from exchange of preferred stock for intellectual property

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the life & health insurance peer group is "buy"

• Wall Street's median 12-month price target for Trupanion Inc is $56.00, about 13.2% above its August 6 closing price of $48.63

• The stock recently traded at 287 times the next 12-month earnings vs. a P/E of 226 three months ago

Press Release: ID:nGNX8KQRmC